Citations

Clear

3942 citation(s) found for "To, Van".

Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome
Heerden, Jon A. van, Sizemore, Glen W., Carney, J. Aidan, Grant, Clive S., ReMine, William H., Sheps, Sheldon G.

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 8 | Issue: 4 | Pages: 612-619

10.1007/bf01654950 | PMID 6148811 Get It

AbstractDuring a 30‐year period (1951–1981), seventeen patients underwent bilateral adrenalectomy for established adrenal medullary disease with catecholamine excess. Fourteen patients had the MEN IIa syndrome and 3 had the MEN IIb syndrome. There was no major operative morbidity and no operative mortality.One patient died 23 months after initial operation because of metastatic pheochromocytoma. The remaining patients were followed for a mean of 129 months and all were personally interviewed. Three patients had 7 uneventful pregnancies. Twelve patients underwent 23 other surgical procedures requiring general anesthesia during the followup period without any morbidity. Two patients have metastatic pheochromocytoma; 3 have clinical metastatic medullary thyroid carcinoma; 5 patients have high calcitonin values and 6 patients are in excellent health at intervals of 15, 27, 58, 110, 134, and 373 months following resection. The need for adrenal replacement therapy has not caused significant problems in any patient.The results of this study confirm that bilateral total adrenalectomy is a safe modality for the treatment of adrenal medullary disease in this syndrome and that it does not produce significant long‐term morbidity.
Book reviews
Heerden, Jonathan A. van, Goldman, M.

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 11 | Issue: 4 | Pages: 553-554

10.1007/bf01655825 Get It

Invited commentary
Heerden, Jon A. van

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 12 | Issue: 5 | Pages: 689-690

10.1007/bf01655887 Get It

Total pancreatectomy for ductal adenocarcinoma of the pancreas: An update
Heerden, Jon A. van, McIlrath, Donald C., Ilstrup, Duane M., Weiland, Louis H.

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 12 | Issue: 5 | Pages: 658-661

10.1007/bf01655878 | PMID 2854327 Get It

AbstractFrom 1951 through December, 1985, a total of 89 patients underwent total pancreatectomy for ductal adenocarcinoma. Of the 89 patients, 54 were male and 35 were female; their average age was 60.0 years. Histologic grading (Broders') demonstrated that 56% of the patients had a grade 2 tumor and 38%, a grade 3 tumor. None of the patients had grade 4 tumors. Peripancreatic lymph nodes were positive in 47% of the patients at the time of resection. Multicentricity was noted in 32.5% of patients. The operative mortality was 10.1%; however, for the patients who had surgery after January, 1980, the operative mortality was 6.2%. At the completion of the study, 78 patients had died and 11 were alive. The principal cause of death was recurrent malignancy. The median duration of survival, including the duration of survival in patients who had operative deaths, was 1.03 years. The influence of sex, tumor grade and size, multicentricity, and nodal status was evaluated multivariately with Cox's proportional hazard model.
Treatment of toxic multinodular goiter (hummer's disease): Surgery or radioiodine?
Gharib, Hossein, Naessens, James M. , Heerden, Jon A. van, Mayberry, W. E., Jensen, Michael Dam

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 10 | Issue: 4 | Pages: 673-679

10.1007/bf01655554 | PMID 3751092 Get It

AbstractThe records of patients treated at the Mayo Clinic for toxic multinodular goiter during 1950–1954, 1960–1964, and 1970–1974 were reviewed to compare results of surgical and131I therapy, to define trends in treatment policy and outcome, and to attempt to elucidate factors associated with posttreatment hypothyroidism. The series involved 446 patients who underwent thyroidectomy as initial treatment and 89 who initially received131I. The time to success was significantly shorter (p=0.001) in surgically treated patients than in patients initially receiving131I. Compared with patients treated medically, patients treated initially with surgery were much less likely to require a second treatment (0% versus 24%) during the first year after initial treatment. The probability of postthyroidectomy hypothyroidism increased from approximately 12% in the 1950s to more than 70% in the 1970s at 2 years after surgery. Neither more aggressive surgery nor use of more sensitive tests to diagnose hypothyroidism accounted for the increased probability in recent years.
Invited commentary
Heerden, Jon A. van

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 10 | Issue: 4 | Pages: 672-672

10.1007/bf01655553 Get It

Clinical management of persistent and/or recurrent primary hyperparathyroidism
Grant, Clive S., Heerden, Jon A. van, Charboneau, J. William, James, E M, Reading, Carl C.

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 10 | Issue: 4 | Pages: 555-563

10.1007/bf01655524 | PMID 3529648 Get It

AbstractPersistent or recurrent hypercalcemia following operation for benign hyperparathyroidism (HPT) remains a surgical challenge. From 1978 to 1984 at the Mayo Clinic, 157 patients underwent reexploration. This included 110 cervical, 38 combined cervical and mediastinal, and 9 mediastinal explorations. A total of 197 previous operations (range 1–5) had been performed, including 136 patients for sporadic disease, 14 for multiple endocrine neoplasia, and 7 for familial HPT. Preoperative localizing studies were employed in 137 patients (87%), Cervical ultrasonography had an accuracy of 76% (sensitivity, 82%; positive predictive value, 81%), while mediastinal computed tomography was accurate in 76% (sensitivity, 57%; positive predictive value, 80%). Arteriography, venography, and venous sampling were not used. Guided by high‐resolution, small parts ultrasonography, fine‐needle aspiration biopsy confirmed localization of parathyroid tissue in 3 patients. Successful resolution of hypercalcemia occurred in 139 patients (89%) with a mean follow‐up of 22 months. There were no operative deaths; 12 patients (8%) had temporary neuropraxia of the recurrent laryngeal nerve, 6 patients (4%) suffered permanent unilateral paralysis, and 20 (13%) became permanently hypoparathyroid. Two of 4 hypoparathyroid patients who were autotransplanted with cryopreserved parathyroid tissue have become eucalcemic. The results indicate that the disease site is usually in the neck, that noninvasive localizing techniques have superseded arteriography and venous sampling, and that reoperative parathyroid surgery can be performed with rare mortality and acceptable morbidity. Although these refinements have led to improved success, reoperative parathyroid surgery should not be performed by the occasional parathyroid surgeon.
Results of adrenal surgery for cushing's syndrome: 10 Years' experience
Watson, Ronald G. K., Heerden, Jon A. van, Northcutt, Robert C., Grant, Clive S., Ilstrup, Duane M.

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 10 | Issue: 4 | Pages: 531-538

10.1007/bf01655518 | PMID 3751085 Get It

AbstractEighty‐nine patients underwent adrenal exploration for Cushing's syndrome at our institution during the period 1970–1979. On the basis of clinical and histological findings related to the initial adrenal operation, patients were divided into 6 major subgroups: (a) adrenocortical adenoma; (b) adrenocortical carcinoma; (c) proven ectopic ACTH adrenocortical hyperplasia; (d) Cushing's disease; (e) uncertain diagnostic group (probably ectopic ACTH syndrome—site unknown); and (f) “non‐ACTH‐dependent” hypercortisolism due to micronodular hyperplasia.Results of pathologic examination included 25 adrenal adenomas, 15 adrenocortical carcinomas, 40 bilateral adrenocortical hyperplasias, and a single case of micronodular hyperplasia. The postoperative mortality rate was 5.6%, and significant morbidity occurred in 40% of patients. Four of the 5 patients who died within 30 days of operation were in the subgroups with adrenal carcinoma (2 patients) and Cushing's disease (2 patients). Survival in patients with adrenocortical adenomas was significantly decreased at 2 years (relative adrenocortical insufficiency?), but thereafter, it paralleled the expected survival. Patients with the ectopic ACTH syndrome and adrenocortical carcinoma had significantly decreased survival, with only one‐third of carcinoma patients alive 2 years postoperatively. The survival of patients with Cushing's disease was lower than expected at both 5 and 10 years.These results confirm that the diagnosis of patients with endogenous hypercortisolism is usually straightforward and accurate, surgical intervention in this group of patients is still accompanied by significant short‐term mortality and morbidity, and long‐term survival in all subgroups is decreased.
Invited commentary
Heerden, Jon A. van

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 9 | Issue: 4 | Pages: 641-642

10.1007/bf01656074 Get It

Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancreatectomy—An institutional perspective
Heerden, Jon A. van

Mayo Clinic

World Journal of Surgery | May 8, 2005 | Volume: 8 | Issue: 6 | Pages: 880-888

10.1007/bf01656028 | PMID 6516431 Get It

AbstractThe collective term “pancreatic cancer” should be replaced by more specific terminology indicating the histological subtype, e.g., pancreatic ductal adenocarcinoma, ampullary adenocarcinoma, duodenal carcinoma, pancreatic cystadenocarcinoma, cholangiocarcinoma, and malignant islet cell carcinoma. Each of these tumors has its own inherent prognostic and therapeutic characteristics‐95% of ampullary lesions being resectable in contrast to ±10% of pancreatic ductal malignancies and comparable 5‐year survival figures for these two subtypes are 40% and 5%, respectively.Since the results of adjuvant therapy (chemo‐ and/or radiotherapy) have been dismal, the only chance of cure remains resective therapy, either by the performance of a total or subtotal pancreatectomy (Whipple procedure). The operative mortality rate for these procedures at our institution has been 12% and 4%, respectively, with corresponding 5‐year survival rates of 2% and 4%. Despite earlier promise that total pancreatectomy only would be a superior procedure (elimination of the pancreatojejunal anastomosis, wider lymphadenectomy, irradication of multicentric disease), the operation has thus far not fulfilled these expectations.The Whipple procedure remains the resective procedure of choice at our institution—total pancreatectomy being performed principally in those patients in whom a safe pancreatojejunal anastomosis cannot be constructed.Value of early diagnosis in patients with ductal adenocarcinoma does not appear to imply improved prognosis. Energies should be diverted toward etiological identification of this lethal malignancy which is steadily increasing in incidence.